Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3FL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $89,713
Award facts
- Contract value 100% obligated
- $89,713.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $89,713.36 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of XGEVA 120 mg/1.7 ml vials. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded without set-aside provisions and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving as a critical vendor for federal medical procurement.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. XGEVA (denosumab), a bone health medication commonly used in oncology and orthopedic treatment, represents one of the specialized pharmaceutical products routinely delivered through this contract vehicle to support Defense Health Agency and other federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FG3FL?
SPE2DR26FG3FL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FG3FL worth?
The government has obligated $89,713 on SPE2DR26FG3FL.
Is contract SPE2DR26FG3FL an order under another contract?
Yes. SPE2DR26FG3FL is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3FL competed?
The extent of competition for SPE2DR26FG3FL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award